134 related articles for article (PubMed ID: 1786232)
1. CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment.
Galderisi S; Mucci A; Mignone ML; Maj M; Kemali D
Schizophr Res; 1991 Dec; 6(1):15-23. PubMed ID: 1786232
[TBL] [Abstract][Full Text] [Related]
2. Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment.
Kemali D; Galderisi S; Maj M; Mucci A; Di Gregorio M; Bucci P
Int J Psychophysiol; 1992 Dec; 13(3):283-90. PubMed ID: 1459885
[TBL] [Abstract][Full Text] [Related]
3. Quantitative EEG of elderly schizophrenic patients.
Omori M; Koshino Y; Murata T; Murata I; Horie T; Isaki K
Jpn J Psychiatry Neurol; 1992 Sep; 46(3):681-92. PubMed ID: 1362590
[TBL] [Abstract][Full Text] [Related]
4. EEG-brain mapping. A method to optimize therapy in schizophrenics using absolute power and center frequency values.
Schellenberg R; Schwarz A; Knorr W; Haufe C
Schizophr Res; 1992 Oct; 8(1):21-9. PubMed ID: 1358183
[TBL] [Abstract][Full Text] [Related]
5. C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment.
Galderisi S; Mucci A; Di Gregorio MR; Bucci P; Maj M; Kemali D
Eur Neuropsychopharmacol; 1990 Nov; 1(1):51-4. PubMed ID: 2136214
[TBL] [Abstract][Full Text] [Related]
6. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
[TBL] [Abstract][Full Text] [Related]
7. Computerized EEG in schizophrenic patients.
Miyauchi T; Tanaka K; Hagimoto H; Miura T; Kishimoto H; Matsushita M
Biol Psychiatry; 1990 Sep; 28(6):488-94. PubMed ID: 2223918
[TBL] [Abstract][Full Text] [Related]
8. EEG coherence in unmedicated schizophrenic patients: topographical study of predominantly never medicated cases.
Nagase Y; Okubo Y; Matsuura M; Kojima T; Toru M
Biol Psychiatry; 1992 Dec; 32(11):1028-34. PubMed ID: 1467383
[TBL] [Abstract][Full Text] [Related]
9. Topographical changes in alpha power in medicated and unmedicated schizophrenics during digits span reverse matching test.
Nagase Y; Okubo Y; Matsuura M; Kojima T
Biol Psychiatry; 1992 Nov; 32(10):870-9. PubMed ID: 1361364
[TBL] [Abstract][Full Text] [Related]
10. EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol.
Saletu B; Küfferle B; Anderer P; Grünberger J; Steinberger K
Eur Neuropsychopharmacol; 1990 Nov; 1(1):27-36. PubMed ID: 1983779
[TBL] [Abstract][Full Text] [Related]
11. Dimensional complexity of EEG brain mechanisms in untreated schizophrenia.
Koukkou M; Lehmann D; Wackermann J; Dvorak I; Henggeler B
Biol Psychiatry; 1993 Mar; 33(6):397-407. PubMed ID: 8098223
[TBL] [Abstract][Full Text] [Related]
12. Slower theta activity over the midfrontal cortex in schizophrenic patients.
Westphal KP; Grözinger B; Diekmann V; Scherb W; Reess J; Leibing U; Kornhuber HH
Acta Psychiatr Scand; 1990 Feb; 81(2):132-8. PubMed ID: 2327275
[TBL] [Abstract][Full Text] [Related]
13. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
Saletu B; Saletu M; Itil T; Marasa J
Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
[No Abstract] [Full Text] [Related]
14. Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters.
Gattaz WF; Mayer S; Ziegler P; Platz M; Gasser T
Eur Arch Psychiatry Clin Neurosci; 1992; 241(6):328-32. PubMed ID: 1504108
[TBL] [Abstract][Full Text] [Related]
15. Negative symptoms and EEG alpha activity in schizophrenic patients.
Merrin EL; Floyd TC
Schizophr Res; 1992 Oct; 8(1):11-20. PubMed ID: 1358182
[TBL] [Abstract][Full Text] [Related]
16. Spectral analysis of EEG during self-paced movements: differences between untreated schizophrenics and normal controls.
Westphal KP; Grözinger B; Becker W; Diekmann V; Scherb W; Reess J; Leibing U; Kornhuber HH
Biol Psychiatry; 1992 May; 31(10):1020-37. PubMed ID: 1511074
[TBL] [Abstract][Full Text] [Related]
17. [EEG performance spectral mapping during drug therapy in a patient with schizophrenic psychosis].
Schellenberg R; Schwarz A; Knorr W; Schindler M
Psychiatr Neurol Med Psychol (Leipz); 1990 Oct; 42(10):618-24. PubMed ID: 1981811
[TBL] [Abstract][Full Text] [Related]
18. Abnormal premovement brain potentials in schizophrenia.
Singh J; Knight RT; Rosenlicht N; Kotun JM; Beckley DJ; Woods DL
Schizophr Res; 1992 Oct; 8(1):31-41. PubMed ID: 1358184
[TBL] [Abstract][Full Text] [Related]
19. Average reference EEG lateralization in schizophrenic patients.
Merrin EL; Floyd TC
J Neuropsychiatry Clin Neurosci; 1991; 3(3):307-14. PubMed ID: 1687964
[TBL] [Abstract][Full Text] [Related]
20. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
